Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
77.40
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Moderna Inc
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
February 11, 2024
Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.
Via
InvestorPlace
Why Is Moderna Stock Trading Lower Today?
February 09, 2024
Moderna long term data indicates a faster decline in efficacy for its RSV vaccine than the RSV vaccines from GSK and Pfizer.
Via
Benzinga
Spotlight on Moderna: Analyzing the Surge in Options Activity
February 09, 2024
Via
Benzinga
7 Stocks to Sell as Fast as You Possibly Can
February 08, 2024
Are you willing to sacrifice your returns just to hold on to these stocks? Each of them is a stock to sell now to save your portfolio.
Via
InvestorPlace
If You Invested $10,000 in Moderna in 2019, This Is How Much You Would Have Today
February 08, 2024
Moderna generated billions of dollars in earnings from its coronavirus vaccine.
Via
The Motley Fool
Exposures
COVID-19
2024 Promises To Bring Pharmaceutical Breakthroughs On The Oncology Front
February 07, 2024
On Thursday, Merck & Co Inc (NYSE: MRK) topped estimates with its fourth quarter revenue and adjusted earnings fueled by its blockbuster cancer drug Keytruda, along with HPV prevention vaccine...
Via
Benzinga
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
January 22, 2024
Via
Benzinga
1 Stock Down 43% to Buy and Hold for 10 Years
January 21, 2024
This biotech isn't just a pandemic stock.
Via
The Motley Fool
3 Doomed Nasdaq Stocks to Dump Before They Dive: February 2024
February 05, 2024
Investors would be smart to steer clear of these companies, each of which is facing problems that seem insurmountable.
Via
InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
On Tuesday, Pfizer Inc (NYSE: PFE) reported mixed results for its fourth quarter. Last year, Pfizer has responded to concerns related to its COVID-19 products being the rearview mirror with a...
Via
Benzinga
Exposures
COVID-19
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Behind the Scenes of Moderna's Latest Options Trends
January 18, 2024
Via
Benzinga
3 Things That Could Help 2023 Loser-Stock Moderna Roar Higher in 2024
January 18, 2024
Moderna may be heading for a new era of growth.
Via
The Motley Fool
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
January 28, 2024
The stock is high risk, but rewards could be great if all works out well for Novavax.
Via
The Motley Fool
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
January 27, 2024
These stocks could deliver top returns now and well into the future.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
1 Growth Stock Down 79% That's a Screaming Buy Right Now, According to Several Wall Street Analysts
January 26, 2024
This biotech's prospects go well beyond COVID-19.
Via
The Motley Fool
3 S&P 500 Stocks With 127% to 170% Upside in 2024, According to Select Wall Street Analysts
January 25, 2024
Wall Street's benchmark index is comprised of 500 companies, three of which could deliver triple-digit upside in the new year.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via
Benzinga
Peering Into Moderna's Recent Short Interest
January 17, 2024
Via
Benzinga
Critical Insights From Moderna Analyst Ratings: What You Need To Know
January 12, 2024
Via
Benzinga
Highlights From the 2024 JPMorgan Health Care Conference
January 22, 2024
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live.
Via
The Motley Fool
If You Invested $10,000 in Moderna at the End of 2019, This Is How Much You Would Have Today
January 21, 2024
Has the stock wiped out its gains since the pandemic?
Via
The Motley Fool
Better Bull Market Buy: Pfizer vs. Moderna
January 20, 2024
There could be a light at the end of the COVID-19 tunnel for both of these beaten-down stocks.
Via
The Motley Fool
Exposures
COVID-19
3 Stocks Poised to Bounce Back After a Brutal 2023
January 18, 2024
These companies, which badly lagged the market last year, now look to be turning things around and could be rebound stocks in the year ahead.
Via
InvestorPlace
Alphabet, Electronic Arts And 2 Other Stocks Insiders Are Selling
January 18, 2024
The Nasdaq 100 closed lower by over 90 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
7 Mighty Healthcare Stocks Changing the Game of Medicine
January 17, 2024
Thanks to the permanent relevance of medical innovations, investors ought to consider looking at these healthcare stocks.
Via
InvestorPlace
3 Struggling Businesses Investors Shouldn't Gamble on This Year
January 17, 2024
These stocks all crashed heavily in 2023, and there is no reason to expect things will get a whole lot better this year.
Via
The Motley Fool
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
January 17, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here.
Via
Benzinga
7 Healthcare Stocks Taking Medicine to the Next Level
January 14, 2024
With advances in technology potentially able to improve the human condition, these are the compelling healthcare stocks to consider.
Via
InvestorPlace
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.